IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis

Clinical Immunology and Immunopathology

Volumn 87, Issue 3, 1998, Pages 309-313

  Perrier, S ^a   Coussediere, C ^a   Dubost, J J ^a   Albuisson, E ^b   Sauvezie, B ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

^b Medicine University   (France)

Author keywords

IL 1 receptor antagonist; Polymorphism; Sjogren's syndrome

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA POLYMORPHISM; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR GENE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME;

EID: 0031781756     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4520     Document Type: Article

References (30)

1. Dinarello C. A., Thompson R. C. Blocking IL-1: Interleukin-1 receptor antagonistin vivoin vitro. Immunol. Today. 12:1991;404-410.
2. Eisenberg S. P., Evans R. J., Arend W. P., Verderber E., Brewer M. T., Hannum C. H., Thompson R. C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 343:1990;341-346.
3. Dripps D. J., Brandhuber B. J., Thompson R. C., Eisenberg S. P. Interleukin-1 receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J. Biol. Chem. 266:1991;10331-10336.
4. Steinkasserer A., Koelble K., Sim R. B. Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL-1RN). Nucleic Acids Res. 19:1991;5095.
5. Tarlow J. K., Blakemore A. I. F., Lennard A., Solari R., Hughes H. N., Steinkasserer A., Duff G. W. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of a 86-bp tandem repeat. Hum. Genet. 91:1993;403-404.
6. Danis V. A., Millington M., Hyland V. J., Grennan D. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1ra) gene polymorphism. Clin. Exp. Immunol. 99:1995;303-310.
7. Blakemore A. I. F., Tarlow J. K., Cork M. J., Gordon C., Emery P., Duff G. W. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 37:1994;1380-1385.
8. Jenkins J. K., Arend W. P. Interleukin-1 receptor antagonist production in human monocytes is induced by IL-1 alpha, IL-3, IL-4 and GM-CSF. Cytokine. 5:1993;407-415.
9. Van Der Poll T., Van Deventer J. H., Ten Cate H., Levi M., Ten Cate J. W. Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxinemia. J. Infect. Dis. 169:1994;665-667.
10. Turner M., Chantry D., Katsikis P., Berger A., Brennan F. M., Feldmann M. Induction of the interleukin-1 receptor antagonist protein by transforming growth factor-beta. Eur. J. Immunol. 21:1991;1635-1639.
11. Tilg H., Vannier E., Vachino G., Dinarello C. A., Mier J. W. Antiinflammatory properties of hepatic acute phase proteins: Preferential induction of interleukin-1 (IL-1) receptor antagonist over interleukin-1β synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178:1993;1629-1634.
12. Vitali C., Bombardieri S., Moutsopoulos H. M. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 36:1993;340-347.
13. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215-1218.
14. Lamey P. J., Nolan A. The recovery of human saliva using the Salivette system. Eur. J. Clin. Chem. Clin. Biochem. 32:1994;727-728.
15. Dubost J. J., Perrier S., Afane M., Viallard J. L., Roux-Lombard P., Baudet-Pommel M., Begue C., Kemeny J. L., Sauvezie B. IL-1 receptor antagonist in saliva: Characterization in normal saliva and reduced concentrations in Sjogren's syndrome (SS). Clin. Exp. Immunol. 106:1996;237-242.
16. Hammerberg C., Arend W. P., Fisher G. J., Chan L. S., Berger A. E., Haskill S., Voorhees J. J., Cooper K. D. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J. Clin. Invest. 90:1992;571-583.
17. Kristensen M., Deleuran B., Eedy D. J., Feldmann M., Breathnach S. M., Brennan F. M. Distribution of interleukin-1 receptor antagonist protein (IRAP), interleukin-1 receptor, and interleukin-1 α in normal and psoriatic skin. Br. J. Dermatol. 127:1992;305-311.
18. Tarlow J. K., Cork M. J., Clay F. E., Schmitt-Egenolf M., Crane A. M., Stierle C., Boehncke W.-H., Eiermann T. H., Blakemore A. I. F., Bleehen S. S., Sterry W., Duff G. W. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br. J. Dermatol. 136:1997;147-148.
19. Clay F. E., Cork M. J., Tarlow J. K., Blakemore A. I. F., Harrington C. I., Lewis F., Duff G. W. Interleukin-1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum. Genet. 94:1994;407-410.
20. Mansfield J. C., Holden H., Tarlow J. K., Di Giovine F. S., McDowell T. L., Wilson A. G., Holdsworth C. D., Duff G. W. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology. 106:1994;637-642.
21. Tarlow J. K., Clay F. E., Cork M. J., Blakemore A. I. F., McDonagh A. J. G., Messenger A. G., Duff G. W. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J. Invest. Dermatol. 103:1994;387-390.
22. Blakemore A. I. F., Watson P. F., Weetman A. P., Duff G. W. Association of Grave's disease with an allele of the interleukin-1 receptor antagonist gene. J. Clin. Endocrinol. Metab. 80:1995;111-115.
23. Blakemore A. I. F., Cox A., Gonzalez A. M., Maskill J. K., Hughes M. E., Wilson R. M., Ward J. D., Duff G. W. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum. Genet. 97:1996;369-374.
24. Nerad J. L., Griffiths J. K., Van der Meer J. W. M., Endres S., Poutsiaka D. D., Keusch G. T., Bennish M., Salam M. A., Dinarello C. A., Cannon J. G. Interleukin-1β (IL-1β), IL-1 receptor antagonist, ant TNF-α production in whole blood. J. Leukocyte Biol. 52:1992;687-692.
25. Suzuki H., Takemura H., Kashiwagi H. Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Arthritis Rheum. 38:1995;1055-1059.
26. Andus T., Gross V., Scholmerich J. Elevated circulatory interleukin-1 receptor antagonist levels in serum of patients with active Crohn's disease and ulcerative colitis. Gastroenterology. 104:1993;A660.
27. Mandrup-Poulsen T., Pociot F., Molvig J., Shapiro L., Nillson P., Emdal T., Roder M., Kjems L. L., Dinarello C. A., Nerup J. Monokine antagonism is reduced in patients with IDDM. Diabetes. 43:1994;1242-1247.
28. Phillips W. G., Feldmann M., Breathnach S. M., Brennan F. M. Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1α and IL-1 receptor antagonist. Clin. Exp. Immunol. 101:1995;177-182.
29. Ogawa N., Dang H., Lazaridis K., McGuff H. S., Aufdemorte T. B., Talal N. Analysis of transforming growth factor beta and other cytokines in autoimmune exocrinopathy (Sjogren's syndrome). J. Interferon Cytokine Res. 15:1995;759-767.
30. Sturfelt G. K., Roux-Lombard P., Dayer J.-M., Wolheim F. A. Interleukin-1 receptor antagonist in the course of SLE: Low levels coincide with kidney involvement. Arthritis Rheum. 39:1996;S296.